Password reminder
No account yet? Register Free
About Us Advertising Info Contact Us Client Login
biotechdaily.com
Genomics/Proteomics
Features Subscription Partner Sites Journal Info
HTL Lab SolutionsROCHE APPLIED SCIENCESANYO EUROPE LTD

Reducing N-Cadherin Increases Survival in Mouse Model of Pancreatic Cancer

By BiotechDaily International staff writers
Posted on 11 Jan 2012


Reduction in the activity of a key membrane adhesive protein causes pancreatic cancer cells to lose the ability to metastasize and spread tumors to other sites within the body.

Pancreatic ductal adenocarcinma (PDA) does not typically produce symptoms until after it has metastasized. Late detection leads to a high mortality rate with a five-year survival rate of less than 5%.

Investigators at Thomas Jefferson University (Philadelphia, PA, USA) worked with lines of genetically engineered mice to determine whether modifying PDA cell surface proteins could block the ability of the cancer to spread.

They reported in the December 12, 2011, online edition of the journal Oncogene that mice with reduced N-cadherin expression survived 25% longer than animals expressing two wild-type N-cadherin (Cdh2) alleles.

Cadherins are members of a family of calcium-dependent cell adhesion proteins that preferentially interact in a homophilic manner in cell-cell interactions. They are type I membrane proteins that contribute to the sorting of heterogeneous cell types. The names of different classes indicate the tissues in which they were first found: E-cadherin is present on many types of epithelial cells; N-cadherin is present on nerve, muscle, and lens cells; and P-cadherin is present on placental and epidermal cells. Typically, cadherins have five similar extracellular domains, the outermost three of which have Ca2+-binding sites, and an intracellular C-terminal domain that interacts with the actin cytoskeleton.

“Previous studies demonstrated the importance of this cell surface protein for tumor cell growth,” said senior author Dr. Glenn Radice, associate professor of medicine at Thomas Jefferson University. “However, it was not clear from those studies whether interfering with N-cadherin levels would increase survival of animals genetically engineered to develop highly metastatic pancreatic cancer. Our survival results are very exciting because a drug, known as ADH-1that specifically targets N-cadherin is already in clinical trial for melanoma. The next step is to test this N-cadherin-function blocking drug or a similar compound in the pancreatic cancer mouse model to see if it can prolong survival.”

Related Links:

Thomas Jefferson University






Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to BiotechDaily.com and get complete access to news and events that shape the world of biotechnology.
Free digital version edition of Bio Research International sent by email on regular basis
Free print version of Bio Research International magazine
(available only outside USA and Canada).
Free and unlimited access to back issues of Bio Research International in digital format
Free Bio Research International Newsletter sent every 2 weeks containing the latest news
Free breaking news sent via email
Free access to Events Calendar
Free access to LinkXpress new product services
REGISTRATION IS FREE AND EASY!


Click here to Register

Sign in: Registered website members
Username: Password:
Forgot username/password? Click here!
Sign in: Registered magazine subscribers
Subcode: Last Name:
What is SUBCODE?

ADVERTISEMENT
GLOBETECH PUBLISHING



Enclosed Workstation
Enclosed Workstation
PCR Microplates
PCR Microplates
High-Throughput Solution
High-Throughput Solution

More Products

Latest Genomics/Proteomics News

LinkXpress
Click for LinkXpress
Reader Inquiry Service
Enter code to receive information:
Where I can find code?
Featured Video
BioTek:
The Race

View Video
Featured Whitepaper
ELGA LABWATER:
Why pure water is important in modern chromatography

Download Whitepaper
Events
ELA 2012 - European Lab Automation.
30 May 2012 - 31 May 2012


Bio International 2012.
18 Jun 2012 - 21 Jun 2012


ACHEMA 2012.
18 Jun 2012 - 22 Jun 2012


More events
Latest Issue

View Digital Edition
Subscribe / Renew
HTL Lab Solutions
VISION-SCIENCES, INC.
WEALTEC BIOSCIENCE CO. LTD
BRAND GMBH + CO
  biotechdaily.com Copyright © 2000-2012 Globetech Media. All rights reserved.
Privacy Policy